Avenue Therapeutics Inc. (ATXI)

1.01

-0.09 (-8.18%)

At close: Mar 03, 2025, 3:55 PM

0.99

-1.86%

After-hours: Mar 03, 2025, 04:44 PM EST

Avenue Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15
Net Income	-10.38M	-3.6M	-3.73M	-5.15M	-25.91M	-21.55M	-12.26M	-3.18M	-5.23M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	174K	n/a	n/a
Stock-Based Compensation	906K	649K	442K	710K	1.84M	1.54M	604K	28K	55.64
Other Working Capital	70K	23K	-55K	57K	982K	670K	-154K	1.07M	1.17M
Other Non-Cash Items	310K	-5.05M	909K	939K	61K	412K	2.32M	435K	3.16M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	277K	n/a	n/a
Change in Working Capital	-290K	408K	-461K	-172K	-2.25M	1.79M	2.08M	1.08M	1.17M
Operating Cash Flow	-9.45M	-7.6M	-3.75M	-4.61M	-26.26M	-18.22M	-6.8M	-1.63M	-895K
Capital Expenditures	-3M	n/a	n/a	-1M	n/a	n/a	n/a	n/a	-3M
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	-5M	10M	-10M	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	5M	10M	n/a	n/a	n/a
Other Investing Acitivies	-3M	n/a	n/a	-1M	n/a	-10M	-10K	n/a	-3.27K
Investing Cash Flow	-3M	n/a	n/a	-1M	n/a	10M	-10M	n/a	-3M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	-3M	1.87M	3.91M
Common Stock Repurchased	n/a	-1.1M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1K	148K	-663K	n/a	-2.67M	-895K	-6.56M	-58K	n/a
Financial Cash Flow	7.53M	10.54M	4.38M	n/a	32.33M	-895K	28.39M	1.81M	3.91M
Net Cash Flow	-4.92M	2.94M	631K	-5.61M	6.07M	-9.11M	11.59M	183K	14K
Free Cash Flow	-12.45M	-7.6M	-3.75M	-5.61M	-26.26M	-18.22M	-6.8M	-1.63M	-3.9M